Advaxis Competitors and Similar CompaniesClear all
Advaxis's competitors and similar companies include KemPharm.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Princeton, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US |
Employees | Employees 3540% decrease | Employees 333% increase |
Valuation ($) | Valuation ($) 2.4 m | Valuation ($) 200.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $13k (FY, 2023) | Revenue (est.) $106.5m (FY, 2025) |
Net income | Net income ($48.1m) (FY, 2023) | Net income $83.2m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View company